PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_0	[0]	[236]	['Low glycaemic index diet in pregnancy to prevent macrosomia (ROLO study): randomised control trial\n\nAbstract\nObjective To determine if a low glycaemic index diet in pregnancy could reduce the incidence of macrosomia in an at risk group.']	pregnancy	GO_BP	[28]	[37]	BMJ_2012_Aug_30_345_e5605_T65
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_0	[0]	[236]	['Low glycaemic index diet in pregnancy to prevent macrosomia (ROLO study): randomised control trial\n\nAbstract\nObjective To determine if a low glycaemic index diet in pregnancy could reduce the incidence of macrosomia in an at risk group.']	pregnancy	GO_BP	[165]	[174]	BMJ_2012_Aug_30_345_e5605_T66
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_3	[320]	[494]	['Participants 800 women without diabetes, all in their second pregnancy between January 2007 to January 2011, having previously delivered an infant weighing greater than 4 kg.']	pregnancy	GO_BP	[381]	[390]	BMJ_2012_Aug_30_345_e5605_T67
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_3	[320]	[494]	['Participants 800 women without diabetes, all in their second pregnancy between January 2007 to January 2011, having previously delivered an infant weighing greater than 4 kg.']	delivered	GO_BP	[447]	[456]	BMJ_2012_Aug_30_345_e5605_T68
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_4	[495]	[625]	['Intervention Women were randomised to receive no dietary intervention or start on a low glycaemic index diet from early pregnancy.']	pregnancy	GO_BP	[615]	[624]	BMJ_2012_Aug_30_345_e5605_T69
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_5	[626]	[699]	['Main outcomes The primary outcome measure was difference in birth weight.']	birth	GO_BP	[686]	[691]	BMJ_2012_Aug_30_345_e5605_T70
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_6	[700]	[772]	['The secondary outcome measure was difference in gestational weight gain.']	gestational	GO_BP	[748]	[759]	BMJ_2012_Aug_30_345_e5605_T71
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_7	[773]	[904]	['Results No significant difference was seen between the two groups in absolute birth weight, birthweight centile, or ponderal index.']	birth	GO_BP	[851]	[856]	BMJ_2012_Aug_30_345_e5605_T72
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_7	[773]	[904]	['Results No significant difference was seen between the two groups in absolute birth weight, birthweight centile, or ponderal index.']	birthweight	GO_BP	[865]	[876]	BMJ_2012_Aug_30_345_e5605_T73
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_8	[905]	[1075]	['Significantly less gestational weight gain occurred in women in the intervention arm (12.2 v 13.7 kg; mean difference −1.3, 95% confidence interval −2.4 to −0.2; P=0.01).']	gestational	GO_BP	[924]	[935]	BMJ_2012_Aug_30_345_e5605_T74
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_9	[1076]	[1326]	['The rate of glucose intolerance was also lower in the intervention arm: 21% (67/320) compared with 28% (100/352) of controls had a fasting glucose of 5.1 mmol/L or greater or a 1 hour glucose challenge test result of greater than 7.8 mmol/L (P=0.02).']	glucose	CHEBI	[1088]	[1095]	BMJ_2012_Aug_30_345_e5605_T0
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_9	[1076]	[1326]	['The rate of glucose intolerance was also lower in the intervention arm: 21% (67/320) compared with 28% (100/352) of controls had a fasting glucose of 5.1 mmol/L or greater or a 1 hour glucose challenge test result of greater than 7.8 mmol/L (P=0.02).']	glucose	CHEBI	[1215]	[1222]	BMJ_2012_Aug_30_345_e5605_T1
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_9	[1076]	[1326]	['The rate of glucose intolerance was also lower in the intervention arm: 21% (67/320) compared with 28% (100/352) of controls had a fasting glucose of 5.1 mmol/L or greater or a 1 hour glucose challenge test result of greater than 7.8 mmol/L (P=0.02).']	glucose	CHEBI	[1260]	[1267]	BMJ_2012_Aug_30_345_e5605_T2
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_10	[1327]	[1483]	['Conclusion A low glycaemic index diet in pregnancy did not reduce the incidence of large for gestational age infants in a group at risk of fetal macrosomia.']	glycaemic	CHEBI	[1344]	[1353]	BMJ_2012_Aug_30_345_e5605_T3
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_10	[1327]	[1483]	['Conclusion A low glycaemic index diet in pregnancy did not reduce the incidence of large for gestational age infants in a group at risk of fetal macrosomia.']	pregnancy	GO_BP	[1368]	[1377]	BMJ_2012_Aug_30_345_e5605_T75
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_10	[1327]	[1483]	['Conclusion A low glycaemic index diet in pregnancy did not reduce the incidence of large for gestational age infants in a group at risk of fetal macrosomia.']	gestational	GO_BP	[1420]	[1431]	BMJ_2012_Aug_30_345_e5605_T76
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_11	[1484]	[1596]	['It did, however, have a significant positive effect on gestational weight gain and maternal glucose intolerance.']	gestational	GO_BP	[1539]	[1550]	BMJ_2012_Aug_30_345_e5605_T77
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_11	[1484]	[1596]	['It did, however, have a significant positive effect on gestational weight gain and maternal glucose intolerance.']	glucose	CHEBI	[1576]	[1583]	BMJ_2012_Aug_30_345_e5605_T4
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	gestational	GO_BP	[1682]	[1693]	BMJ_2012_Aug_30_345_e5605_T78
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	delivery	GO_BP	[1797]	[1805]	BMJ_2012_Aug_30_345_e5605_T79
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	birth	GO_BP	[1860]	[1865]	BMJ_2012_Aug_30_345_e5605_T80
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	adolescence	GO_BP	[2034]	[2045]	BMJ_2012_Aug_30_345_e5605_T81
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	adulthood	UBERON	[2057]	[2066]	BMJ_2012_Aug_30_345_e5605_T252
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	cardiovascular	UBERON	[2123]	[2137]	BMJ_2012_Aug_30_345_e5605_T253
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	metabolic	GO_BP	[2142]	[2151]	BMJ_2012_Aug_30_345_e5605_T82
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	life	UBERON	[2175]	[2179]	BMJ_2012_Aug_30_345_e5605_T254
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	birth	GO_BP	[2209]	[2214]	BMJ_2012_Aug_30_345_e5605_T83
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	delivery	GO_BP	[2279]	[2287]	BMJ_2012_Aug_30_345_e5605_T84
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	gestational	GO_BP	[2303]	[2314]	BMJ_2012_Aug_30_345_e5605_T85
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	gestational	GO_BP	[2352]	[2363]	BMJ_2012_Aug_30_345_e5605_T86
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	birth	GO_BP	[2409]	[2414]	BMJ_2012_Aug_30_345_e5605_T87
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	delivering	GO_BP	[2488]	[2498]	BMJ_2012_Aug_30_345_e5605_T88
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	birth	GO_BP	[2609]	[2614]	BMJ_2012_Aug_30_345_e5605_T89
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	Glucose	CHEBI	[2627]	[2634]	BMJ_2012_Aug_30_345_e5605_T5
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	glucose	CHEBI	[2862]	[2869]	BMJ_2012_Aug_30_345_e5605_T6
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	carbohydrate	CHEBI	[3041]	[3053]	BMJ_2012_Aug_30_345_e5605_T7
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	blood	UBERON	[3075]	[3080]	BMJ_2012_Aug_30_345_e5605_T255
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_13	[1659]	[3104]	['Introduction\nLarge for gestational age or macrosomic infants are predisposed to a variety of adverse obstetric and neonatal outcomes, and delivery of a large infant significantly increases the risk of birth complications for the mother.12In the long term, infants at the highest end of the distribution for weight or body mass index are more likely to be obese in childhood, adolescence, and early adulthood than are other infants,3and they are at greater risk of cardiovascular and metabolic complications later in life.45\nSeveral factors influence birth weight, including maternal age, parity, ethnicity, and previous delivery of a large for gestational age infant.6Both maternal weight and gestational weight gain exert a significant influence on birth weight.789Increased maternal body mass index confers an elevated risk of delivering a heavier infant,10and evidence supports a strong associations between excessive weight gain and an increased birth weight.1112\nGlucose is the main energy substrate for fetal growth.13Birth weights in infants of mothers with diabetes are increased; up to 35% are above the 95th centile.14Moreover, a strong, continuous association has been shown between maternal glucose concentrations below those diagnostic of diabetes and the incidence of macrosomia and its inherent complications.15Maternal diet, and particularly the type and content of carbohydrate, influences maternal blood glucose concentrations.']	glucose	CHEBI	[3081]	[3088]	BMJ_2012_Aug_30_345_e5605_T8
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_14	[3105]	[3181]	['However, different carbohydrate foods produce different glycaemic responses.']	carbohydrate	CHEBI	[3124]	[3136]	BMJ_2012_Aug_30_345_e5605_T9
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_14	[3105]	[3181]	['However, different carbohydrate foods produce different glycaemic responses.']	foods	CHEBI	[3137]	[3142]	BMJ_2012_Aug_30_345_e5605_T10
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_14	[3105]	[3181]	['However, different carbohydrate foods produce different glycaemic responses.']	glycaemic	GO_BP	[3161]	[3170]	BMJ_2012_Aug_30_345_e5605_T90
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	glycaemic	GO_BP	[3258]	[3267]	BMJ_2012_Aug_30_345_e5605_T91
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	carbohydrates	CHEBI	[3291]	[3304]	BMJ_2012_Aug_30_345_e5605_T11
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	insulin	PR	[3374]	[3381]	BMJ_2012_Aug_30_345_e5605_T248
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	pregnancy	GO_BP	[3409]	[3418]	BMJ_2012_Aug_30_345_e5605_T92
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	glycaemic	CHEBI	[3483]	[3492]	BMJ_2012_Aug_30_345_e5605_T12
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	carbohydrate	CHEBI	[3493]	[3505]	BMJ_2012_Aug_30_345_e5605_T13
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	foods	CHEBI	[3506]	[3511]	BMJ_2012_Aug_30_345_e5605_T14
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	feto	UBERON	[3539]	[3543]	BMJ_2012_Aug_30_345_e5605_T256
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	placental	UBERON	[3544]	[3553]	BMJ_2012_Aug_30_345_e5605_T257
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	intake	GO_BP	[3661]	[3667]	BMJ_2012_Aug_30_345_e5605_T93
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	glycaemic	CHEBI	[3675]	[3684]	BMJ_2012_Aug_30_345_e5605_T15
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	carbohydrates	CHEBI	[3685]	[3698]	BMJ_2012_Aug_30_345_e5605_T16
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	birth	GO_BP	[3728]	[3733]	BMJ_2012_Aug_30_345_e5605_T94
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_15	[3182]	[3950]	['Jenkins developed the glycaemic index in 1981 as a method for assessing the glycaemic responses to different carbohydrates.16A low glycaemic index diet has been shown to blunt the increase in insulin resistance in mid and late pregnancy typically seen in westernised societies.17Eating primarily high glycaemic carbohydrate foods is postulated to result in feto-placental overgrowth and excessive maternal weight gain and to lead to a predisposition to fetal macrosomia, whereas intake of low glycaemic carbohydrates predisposes to normal infant birth weight and normal maternal weight gain.1318To date, the effect of introducing a low glycaemic index diet in pregnancy to reduce the incidence of fetal macrosomia has not been subject to a randomised controlled trial.']	pregnancy	GO_BP	[3842]	[3851]	BMJ_2012_Aug_30_345_e5605_T95
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_16	[3951]	[4324]	['Fetal macrosomia recurs in a second pregnancy in 30-50% of cases, and gestational weight gain influences this risk.1920Our objective was to do a randomised controlled trial of a low glycaemic index diet from early pregnancy in a group of women all in their second pregnancies (secundigravid) who had previously delivered an infant weighing greater than 4000 g (ROLO study).']	pregnancy	GO_BP	[3987]	[3996]	BMJ_2012_Aug_30_345_e5605_T96
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_16	[3951]	[4324]	['Fetal macrosomia recurs in a second pregnancy in 30-50% of cases, and gestational weight gain influences this risk.1920Our objective was to do a randomised controlled trial of a low glycaemic index diet from early pregnancy in a group of women all in their second pregnancies (secundigravid) who had previously delivered an infant weighing greater than 4000 g (ROLO study).']	gestational	GO_BP	[4021]	[4032]	BMJ_2012_Aug_30_345_e5605_T97
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_16	[3951]	[4324]	['Fetal macrosomia recurs in a second pregnancy in 30-50% of cases, and gestational weight gain influences this risk.1920Our objective was to do a randomised controlled trial of a low glycaemic index diet from early pregnancy in a group of women all in their second pregnancies (secundigravid) who had previously delivered an infant weighing greater than 4000 g (ROLO study).']	pregnancy	GO_BP	[4165]	[4174]	BMJ_2012_Aug_30_345_e5605_T98
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_16	[3951]	[4324]	['Fetal macrosomia recurs in a second pregnancy in 30-50% of cases, and gestational weight gain influences this risk.1920Our objective was to do a randomised controlled trial of a low glycaemic index diet from early pregnancy in a group of women all in their second pregnancies (secundigravid) who had previously delivered an infant weighing greater than 4000 g (ROLO study).']	pregnancies	GO_BP	[4215]	[4226]	BMJ_2012_Aug_30_345_e5605_T99
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_16	[3951]	[4324]	['Fetal macrosomia recurs in a second pregnancy in 30-50% of cases, and gestational weight gain influences this risk.1920Our objective was to do a randomised controlled trial of a low glycaemic index diet from early pregnancy in a group of women all in their second pregnancies (secundigravid) who had previously delivered an infant weighing greater than 4000 g (ROLO study).']	delivered	GO_BP	[4262]	[4271]	BMJ_2012_Aug_30_345_e5605_T100
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_18	[4425]	[4774]	['The primary outcome measure was difference in birth weight between the intervention and control groups, and the secondary outcome was difference in gestational weight gain.21\n\nMethods\nThis was a randomised control trial with institutional ethical approval and maternal written consent carried out at the National Maternity Hospital, Dublin, Ireland.']	birth	GO_BP	[4471]	[4476]	BMJ_2012_Aug_30_345_e5605_T101
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_18	[4425]	[4774]	['The primary outcome measure was difference in birth weight between the intervention and control groups, and the secondary outcome was difference in gestational weight gain.21\n\nMethods\nThis was a randomised control trial with institutional ethical approval and maternal written consent carried out at the National Maternity Hospital, Dublin, Ireland.']	gestational	GO_BP	[4573]	[4584]	BMJ_2012_Aug_30_345_e5605_T102
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_18	[4425]	[4774]	['The primary outcome measure was difference in birth weight between the intervention and control groups, and the secondary outcome was difference in gestational weight gain.21\n\nMethods\nThis was a randomised control trial with institutional ethical approval and maternal written consent carried out at the National Maternity Hospital, Dublin, Ireland.']	Maternity	UBERON	[4738]	[4747]	BMJ_2012_Aug_30_345_e5605_T258
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_19	[4776]	[4991]	['Patient selection\nAll secundigravid women who had previously delivered a macrosomic infant weighing greater than 4 kg were identified on first contact with the hospital and recruited at first antenatal consultation.']	delivered	GO_BP	[4837]	[4846]	BMJ_2012_Aug_30_345_e5605_T103
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_19	[4776]	[4991]	['Patient selection\nAll secundigravid women who had previously delivered a macrosomic infant weighing greater than 4 kg were identified on first contact with the hospital and recruited at first antenatal consultation.']	antenatal	GO_BP	[4968]	[4977]	BMJ_2012_Aug_30_345_e5605_T104
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_20	[4992]	[5187]	['At this visit, women with any underlying medical disorders, including a previous history of gestational diabetes, those on any drugs, and those unable to give full informed consent were excluded.']	gestational	GO_BP	[5084]	[5095]	BMJ_2012_Aug_30_345_e5605_T105
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_20	[4992]	[5187]	['At this visit, women with any underlying medical disorders, including a previous history of gestational diabetes, those on any drugs, and those unable to give full informed consent were excluded.']	drugs	CHEBI	[5119]	[5124]	BMJ_2012_Aug_30_345_e5605_T17
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_21	[5188]	[5298]	['Other exclusion criteria were age less than 18 years, gestation greater than 18 weeks, and multiple pregnancy.']	gestation	GO_BP	[5242]	[5251]	BMJ_2012_Aug_30_345_e5605_T106
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_21	[5188]	[5298]	['Other exclusion criteria were age less than 18 years, gestation greater than 18 weeks, and multiple pregnancy.']	pregnancy	GO_BP	[5288]	[5297]	BMJ_2012_Aug_30_345_e5605_T107
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_24	[5582]	[5660]	['Dietary intervention\nWomen in the control arm received routine antenatal care.']	antenatal	GO_BP	[5645]	[5654]	BMJ_2012_Aug_30_345_e5605_T108
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_25	[5661]	[5801]	['As is standard practice at our institution, this did not involve any formal dietary advice or specific advice about gestational weight gain.']	gestational	GO_BP	[5777]	[5788]	BMJ_2012_Aug_30_345_e5605_T109
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_26	[5802]	[5960]	['Women randomised to the intervention group attended one dietary education session lasting two hours in groups of two to six women with the research dietitian.']	dietary education	GO_BP	[5858]	[5875]	BMJ_2012_Aug_30_345_e5605_T110
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_27	[5961]	[6049]	['The mean gestational age of those attending the dietary session was 15.7 (SD 3.0) weeks.']	gestational	GO_BP	[5970]	[5981]	BMJ_2012_Aug_30_345_e5605_T111
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_28	[6050]	[6229]	['The diet was designed to meet current recommendations for pregnant women.22Women were first advised on general healthy eating guidelines for pregnancy, following the food pyramid.']	pregnant	GO_BP	[6108]	[6116]	BMJ_2012_Aug_30_345_e5605_T112
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_28	[6050]	[6229]	['The diet was designed to meet current recommendations for pregnant women.22Women were first advised on general healthy eating guidelines for pregnancy, following the food pyramid.']	healthy eating	GO_BP	[6161]	[6175]	BMJ_2012_Aug_30_345_e5605_T113
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_28	[6050]	[6229]	['The diet was designed to meet current recommendations for pregnant women.22Women were first advised on general healthy eating guidelines for pregnancy, following the food pyramid.']	pregnancy	GO_BP	[6191]	[6200]	BMJ_2012_Aug_30_345_e5605_T114
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_28	[6050]	[6229]	['The diet was designed to meet current recommendations for pregnant women.22Women were first advised on general healthy eating guidelines for pregnancy, following the food pyramid.']	food	CHEBI	[6216]	[6220]	BMJ_2012_Aug_30_345_e5605_T18
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_29	[6230]	[6360]	['The remainder of the education session focused on the glycaemic index—its definition, concept, and rationale for use in pregnancy.']	pregnancy	GO_BP	[6350]	[6359]	BMJ_2012_Aug_30_345_e5605_T115
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_30	[6361]	[6527]	['Women were encouraged to choose as many low glycaemic index foods as possible and to exchange high glycaemic index carbohydrates for low glycaemic index alternatives.']	foods	CHEBI	[6421]	[6426]	BMJ_2012_Aug_30_345_e5605_T19
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_30	[6361]	[6527]	['Women were encouraged to choose as many low glycaemic index foods as possible and to exchange high glycaemic index carbohydrates for low glycaemic index alternatives.']	carbohydrates	CHEBI	[6476]	[6489]	BMJ_2012_Aug_30_345_e5605_T20
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_31	[6528]	[6636]	['Women received written resources about low glycaemic index foods after the education session (web appendix).']	foods	CHEBI	[6587]	[6592]	BMJ_2012_Aug_30_345_e5605_T21
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_33	[6758]	[6926]	['The research dietitian met with the patients at 28 and 34 weeks’ gestation for reinforcement of the low glycaemic index diet and to answer any dietary queries they had.']	gestation	GO_BP	[6823]	[6832]	BMJ_2012_Aug_30_345_e5605_T116
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_34	[6928]	[7091]	['Data collection and trial management\nAt their first antenatal consultation, all patients had their weight and height recorded and their body mass index calculated.']	antenatal	GO_BP	[6980]	[6989]	BMJ_2012_Aug_30_345_e5605_T117
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_35	[7092]	[7170]	['Fasting blood glucose was measured and a mid upper arm circumference recorded.']	glucose	CHEBI	[7106]	[7113]	BMJ_2012_Aug_30_345_e5605_T22
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_35	[7092]	[7170]	['Fasting blood glucose was measured and a mid upper arm circumference recorded.']	arm	UBERON	[7143]	[7146]	BMJ_2012_Aug_30_345_e5605_T259
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_37	[7268]	[7328]	['Maternal weight was recorded at each antenatal consultation.']	antenatal	GO_BP	[7305]	[7314]	BMJ_2012_Aug_30_345_e5605_T118
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_38	[7329]	[7476]	['At 28 weeks’ gestation, repeat fasting blood glucose was measured and glucose challenge testing one hour after a 50 g glucose load was carried out.']	gestation	GO_BP	[7342]	[7351]	BMJ_2012_Aug_30_345_e5605_T119
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_38	[7329]	[7476]	['At 28 weeks’ gestation, repeat fasting blood glucose was measured and glucose challenge testing one hour after a 50 g glucose load was carried out.']	blood	UBERON	[7368]	[7373]	BMJ_2012_Aug_30_345_e5605_T260
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_38	[7329]	[7476]	['At 28 weeks’ gestation, repeat fasting blood glucose was measured and glucose challenge testing one hour after a 50 g glucose load was carried out.']	glucose	CHEBI	[7374]	[7381]	BMJ_2012_Aug_30_345_e5605_T23
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_38	[7329]	[7476]	['At 28 weeks’ gestation, repeat fasting blood glucose was measured and glucose challenge testing one hour after a 50 g glucose load was carried out.']	glucose	CHEBI	[7399]	[7406]	BMJ_2012_Aug_30_345_e5605_T24
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_38	[7329]	[7476]	['At 28 weeks’ gestation, repeat fasting blood glucose was measured and glucose challenge testing one hour after a 50 g glucose load was carried out.']	glucose	CHEBI	[7447]	[7454]	BMJ_2012_Aug_30_345_e5605_T25
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_39	[7477]	[7672]	['In accordance with the institutional policy, women with a glucose challenge test result of 8.3 mmol/L or greater had formal glucose tolerance testing carried out to rule out gestational diabetes.']	glucose	CHEBI	[7535]	[7542]	BMJ_2012_Aug_30_345_e5605_T26
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_39	[7477]	[7672]	['In accordance with the institutional policy, women with a glucose challenge test result of 8.3 mmol/L or greater had formal glucose tolerance testing carried out to rule out gestational diabetes.']	glucose	CHEBI	[7601]	[7608]	BMJ_2012_Aug_30_345_e5605_T27
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_39	[7477]	[7672]	['In accordance with the institutional policy, women with a glucose challenge test result of 8.3 mmol/L or greater had formal glucose tolerance testing carried out to rule out gestational diabetes.']	gestational	GO_BP	[7651]	[7662]	BMJ_2012_Aug_30_345_e5605_T120
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_40	[7673]	[7977]	['Gestational diabetes was diagnosed when an abnormal glucose challenge test was followed by two or more abnormal values on a three hour 100 g glucose tolerance test using the Carpenter and Coustan criteria.23When gestational diabetes was diagnosed, care continued in the multidisciplinary diabetic clinic.']	Gestational	GO_BP	[7673]	[7684]	BMJ_2012_Aug_30_345_e5605_T121
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_40	[7673]	[7977]	['Gestational diabetes was diagnosed when an abnormal glucose challenge test was followed by two or more abnormal values on a three hour 100 g glucose tolerance test using the Carpenter and Coustan criteria.23When gestational diabetes was diagnosed, care continued in the multidisciplinary diabetic clinic.']	glucose	CHEBI	[7725]	[7732]	BMJ_2012_Aug_30_345_e5605_T28
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_40	[7673]	[7977]	['Gestational diabetes was diagnosed when an abnormal glucose challenge test was followed by two or more abnormal values on a three hour 100 g glucose tolerance test using the Carpenter and Coustan criteria.23When gestational diabetes was diagnosed, care continued in the multidisciplinary diabetic clinic.']	glucose	CHEBI	[7814]	[7821]	BMJ_2012_Aug_30_345_e5605_T29
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_40	[7673]	[7977]	['Gestational diabetes was diagnosed when an abnormal glucose challenge test was followed by two or more abnormal values on a three hour 100 g glucose tolerance test using the Carpenter and Coustan criteria.23When gestational diabetes was diagnosed, care continued in the multidisciplinary diabetic clinic.']	gestational	GO_BP	[7885]	[7896]	BMJ_2012_Aug_30_345_e5605_T122
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_41	[7978]	[8049]	['We assessed fetal biometry ultrasonographically at 34 weeks’ gestation.']	gestation	GO_BP	[8039]	[8048]	BMJ_2012_Aug_30_345_e5605_T123
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_42	[8050]	[8117]	['This included a measurement of fetal anterior abdominal wall width.']	abdominal wall	UBERON	[8096]	[8110]	BMJ_2012_Aug_30_345_e5605_T261
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_44	[8352]	[8497]	['At delivery, we recorded infants’ birth weight, length, and head circumference and calculated the ponderal index (100 × mass in g/height in cm3).']	delivery	GO_BP	[8355]	[8363]	BMJ_2012_Aug_30_345_e5605_T124
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_44	[8352]	[8497]	['At delivery, we recorded infants’ birth weight, length, and head circumference and calculated the ponderal index (100 × mass in g/height in cm3).']	birth	GO_BP	[8386]	[8391]	BMJ_2012_Aug_30_345_e5605_T125
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_44	[8352]	[8497]	['At delivery, we recorded infants’ birth weight, length, and head circumference and calculated the ponderal index (100 × mass in g/height in cm3).']	head	UBERON	[8412]	[8416]	BMJ_2012_Aug_30_345_e5605_T262
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_45	[8498]	[8743]	['We used Gestation Network’s Bulk Calculator version 6.2.3 UK to calculate birthweight centiles corrected for maternal weight, height, parity, ethnicity, gestational age at delivery, and infant’s sex.26\nThe trial steering committee met bimonthly.']	Gestation	GO_BP	[8506]	[8515]	BMJ_2012_Aug_30_345_e5605_T126
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_45	[8498]	[8743]	['We used Gestation Network’s Bulk Calculator version 6.2.3 UK to calculate birthweight centiles corrected for maternal weight, height, parity, ethnicity, gestational age at delivery, and infant’s sex.26\nThe trial steering committee met bimonthly.']	gestational	GO_BP	[8651]	[8662]	BMJ_2012_Aug_30_345_e5605_T127
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_45	[8498]	[8743]	['We used Gestation Network’s Bulk Calculator version 6.2.3 UK to calculate birthweight centiles corrected for maternal weight, height, parity, ethnicity, gestational age at delivery, and infant’s sex.26\nThe trial steering committee met bimonthly.']	delivery	GO_BP	[8670]	[8678]	BMJ_2012_Aug_30_345_e5605_T128
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_47	[8862]	[9032]	['Dietary assessment\nAll women completed three food diaries of three days each—one before dietary intervention and one each in the second and third trimesters of pregnancy.']	food	CHEBI	[8907]	[8911]	BMJ_2012_Aug_30_345_e5605_T30
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_47	[8862]	[9032]	['Dietary assessment\nAll women completed three food diaries of three days each—one before dietary intervention and one each in the second and third trimesters of pregnancy.']	trimesters	GO_BP	[9008]	[9018]	BMJ_2012_Aug_30_345_e5605_T129
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_47	[8862]	[9032]	['Dietary assessment\nAll women completed three food diaries of three days each—one before dietary intervention and one each in the second and third trimesters of pregnancy.']	pregnancy	GO_BP	[9022]	[9031]	BMJ_2012_Aug_30_345_e5605_T130
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_48	[9033]	[9168]	['These collected information on typical meal pattern and food choices over three days and allowed for estimation of the glycaemic index.']	food	CHEBI	[9089]	[9093]	BMJ_2012_Aug_30_345_e5605_T31
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_48	[9033]	[9168]	['These collected information on typical meal pattern and food choices over three days and allowed for estimation of the glycaemic index.']	food choices	GO_BP	[9089]	[9101]	BMJ_2012_Aug_30_345_e5605_T131
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_48	[9033]	[9168]	['These collected information on typical meal pattern and food choices over three days and allowed for estimation of the glycaemic index.']	glycaemic	GO_BP	[9152]	[9161]	BMJ_2012_Aug_30_345_e5605_T132
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_49	[9169]	[9388]	['We calculated the glycaemic load as the mathematical product of the glycaemic index of a food and its carbohydrate content in grams divided by 100 (glycaemic load=glycaemic index/100 × amount of available carbohydrate).']	food	CHEBI	[9258]	[9262]	BMJ_2012_Aug_30_345_e5605_T32
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_49	[9169]	[9388]	['We calculated the glycaemic load as the mathematical product of the glycaemic index of a food and its carbohydrate content in grams divided by 100 (glycaemic load=glycaemic index/100 × amount of available carbohydrate).']	carbohydrate	CHEBI	[9271]	[9283]	BMJ_2012_Aug_30_345_e5605_T33
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_49	[9169]	[9388]	['We calculated the glycaemic load as the mathematical product of the glycaemic index of a food and its carbohydrate content in grams divided by 100 (glycaemic load=glycaemic index/100 × amount of available carbohydrate).']	carbohydrate	CHEBI	[9374]	[9386]	BMJ_2012_Aug_30_345_e5605_T34
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_50	[9389]	[9534]	['To assess adherence to the low glycaemic index diet, we gave patients in the intervention group a questionnaire at their 34 week antenatal visit.']	antenatal	GO_BP	[9518]	[9527]	BMJ_2012_Aug_30_345_e5605_T133
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_52	[9694]	[9985]	['Sample size\nA sample size calculation based on a significance level set at 5% and power set at 90% indicated that we needed 360 patients in each group to detect a 0.25 standard deviation difference in birth weight between the two groups, equivalent to a 102 g difference in the birth weight.']	birth	GO_BP	[9895]	[9900]	BMJ_2012_Aug_30_345_e5605_T134
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_52	[9694]	[9985]	['Sample size\nA sample size calculation based on a significance level set at 5% and power set at 90% indicated that we needed 360 patients in each group to detect a 0.25 standard deviation difference in birth weight between the two groups, equivalent to a 102 g difference in the birth weight.']	birth	GO_BP	[9972]	[9977]	BMJ_2012_Aug_30_345_e5605_T135
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_53	[9987]	[10112]	['Statistical analysis\nWe did the primary analysis with an independent samples t test with birth weight as the primary outcome.']	birth	GO_BP	[10076]	[10081]	BMJ_2012_Aug_30_345_e5605_T136
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_60	[10598]	[10707]	['Results\nThe study period was from January 2007 to January 2011, and the final women delivered in August 2011.']	delivered	GO_BP	[10682]	[10691]	BMJ_2012_Aug_30_345_e5605_T137
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_61	[10708]	[10919]	['During the study period, 909 women in their second pregnancies who met inclusion criteria having previously delivered an infant weighing greater than 4000 g were contacted by telephone and informed of the study.']	second	GO_BP	[10752]	[10758]	BMJ_2012_Aug_30_345_e5605_T138
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_61	[10708]	[10919]	['During the study period, 909 women in their second pregnancies who met inclusion criteria having previously delivered an infant weighing greater than 4000 g were contacted by telephone and informed of the study.']	pregnancies	GO_BP	[10759]	[10770]	BMJ_2012_Aug_30_345_e5605_T139
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_61	[10708]	[10919]	['During the study period, 909 women in their second pregnancies who met inclusion criteria having previously delivered an infant weighing greater than 4000 g were contacted by telephone and informed of the study.']	delivered	GO_BP	[10816]	[10825]	BMJ_2012_Aug_30_345_e5605_T140
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_63	[10968]	[11093]	['A further 51 women met exclusion criteria or miscarried before randomisation, and 800 were recruited and randomised (figure).']	miscarried	GO_BP	[11013]	[11023]	BMJ_2012_Aug_30_345_e5605_T141
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_64	[11094]	[11238]	['One stillbirth occurred in the intervention arm (an infant at 39 weeks’ gestation weighing 2.9 kg; postmortem examination confirmed trisomy 21).']	gestation	GO_BP	[11166]	[11175]	BMJ_2012_Aug_30_345_e5605_T142
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_64	[11094]	[11238]	['One stillbirth occurred in the intervention arm (an infant at 39 weeks’ gestation weighing 2.9 kg; postmortem examination confirmed trisomy 21).']	postmortem	GO_BP	[11193]	[11203]	BMJ_2012_Aug_30_345_e5605_T143
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_67	[11395]	[11678]	['Early pregnancy loss=miscarriage/termination at <14 weeks’ gestation; mid-trimester loss=loss at >14 but <24 weeks’ gestation; stillbirth=fetal demise at >24 weeks’ gestation\n\nCaption (TABLE-WRAP): TABLE 1\n\n\u2002Baseline characteristics at recruitment of control and intervention groups.']	pregnancy	GO_BP	[11401]	[11410]	BMJ_2012_Aug_30_345_e5605_T144
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_67	[11395]	[11678]	['Early pregnancy loss=miscarriage/termination at <14 weeks’ gestation; mid-trimester loss=loss at >14 but <24 weeks’ gestation; stillbirth=fetal demise at >24 weeks’ gestation\n\nCaption (TABLE-WRAP): TABLE 1\n\n\u2002Baseline characteristics at recruitment of control and intervention groups.']	miscarriage	GO_BP	[11416]	[11427]	BMJ_2012_Aug_30_345_e5605_T145
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_67	[11395]	[11678]	['Early pregnancy loss=miscarriage/termination at <14 weeks’ gestation; mid-trimester loss=loss at >14 but <24 weeks’ gestation; stillbirth=fetal demise at >24 weeks’ gestation\n\nCaption (TABLE-WRAP): TABLE 1\n\n\u2002Baseline characteristics at recruitment of control and intervention groups.']	gestation	GO_BP	[11454]	[11463]	BMJ_2012_Aug_30_345_e5605_T146
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_67	[11395]	[11678]	['Early pregnancy loss=miscarriage/termination at <14 weeks’ gestation; mid-trimester loss=loss at >14 but <24 weeks’ gestation; stillbirth=fetal demise at >24 weeks’ gestation\n\nCaption (TABLE-WRAP): TABLE 1\n\n\u2002Baseline characteristics at recruitment of control and intervention groups.']	gestation	GO_BP	[11511]	[11520]	BMJ_2012_Aug_30_345_e5605_T147
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_67	[11395]	[11678]	['Early pregnancy loss=miscarriage/termination at <14 weeks’ gestation; mid-trimester loss=loss at >14 but <24 weeks’ gestation; stillbirth=fetal demise at >24 weeks’ gestation\n\nCaption (TABLE-WRAP): TABLE 1\n\n\u2002Baseline characteristics at recruitment of control and intervention groups.']	stillbirth	GO_BP	[11522]	[11532]	BMJ_2012_Aug_30_345_e5605_T148
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_67	[11395]	[11678]	['Early pregnancy loss=miscarriage/termination at <14 weeks’ gestation; mid-trimester loss=loss at >14 but <24 weeks’ gestation; stillbirth=fetal demise at >24 weeks’ gestation\n\nCaption (TABLE-WRAP): TABLE 1\n\n\u2002Baseline characteristics at recruitment of control and intervention groups.']	demise	GO_BP	[11539]	[11545]	BMJ_2012_Aug_30_345_e5605_T149
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_67	[11395]	[11678]	['Early pregnancy loss=miscarriage/termination at <14 weeks’ gestation; mid-trimester loss=loss at >14 but <24 weeks’ gestation; stillbirth=fetal demise at >24 weeks’ gestation\n\nCaption (TABLE-WRAP): TABLE 1\n\n\u2002Baseline characteristics at recruitment of control and intervention groups.']	gestation	GO_BP	[11560]	[11569]	BMJ_2012_Aug_30_345_e5605_T150
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_68	[11679]	[12262]	['Values are mean (SD) unless stated otherwiseBaseline characteristicIntervention group (n=383)Control group (n=398)Age (years)32.0 (4.2)32.0 (4.2)Gestational age at recruitment (weeks)13.0 (2.3)12.9 (2.2)Weight (kg)73.8 (14.8)73.4 (13.7)Height (cm)166.3 (6.4)168.9 (6.5)Body mass index (kg/m2)26.8 (5.1)26.8 (4.8)Mid upper arm circumference (cm)29.5 (3.6)29.5 (3.4)Fasting glucose (mmol/L)4.5 (0.36)4.5 (0.38)Previous birth weight (g)4253 (261)4242 (236)No (%) smokers17 (4)12 (3)\n\nPrimary outcome\nWe found no significant difference between the two groups in birth weight at delivery.']	Gestational	GO_BP	[11824]	[11835]	BMJ_2012_Aug_30_345_e5605_T151
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_68	[11679]	[12262]	['Values are mean (SD) unless stated otherwiseBaseline characteristicIntervention group (n=383)Control group (n=398)Age (years)32.0 (4.2)32.0 (4.2)Gestational age at recruitment (weeks)13.0 (2.3)12.9 (2.2)Weight (kg)73.8 (14.8)73.4 (13.7)Height (cm)166.3 (6.4)168.9 (6.5)Body mass index (kg/m2)26.8 (5.1)26.8 (4.8)Mid upper arm circumference (cm)29.5 (3.6)29.5 (3.4)Fasting glucose (mmol/L)4.5 (0.36)4.5 (0.38)Previous birth weight (g)4253 (261)4242 (236)No (%) smokers17 (4)12 (3)\n\nPrimary outcome\nWe found no significant difference between the two groups in birth weight at delivery.']	arm	UBERON	[12001]	[12004]	BMJ_2012_Aug_30_345_e5605_T263
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_68	[11679]	[12262]	['Values are mean (SD) unless stated otherwiseBaseline characteristicIntervention group (n=383)Control group (n=398)Age (years)32.0 (4.2)32.0 (4.2)Gestational age at recruitment (weeks)13.0 (2.3)12.9 (2.2)Weight (kg)73.8 (14.8)73.4 (13.7)Height (cm)166.3 (6.4)168.9 (6.5)Body mass index (kg/m2)26.8 (5.1)26.8 (4.8)Mid upper arm circumference (cm)29.5 (3.6)29.5 (3.4)Fasting glucose (mmol/L)4.5 (0.36)4.5 (0.38)Previous birth weight (g)4253 (261)4242 (236)No (%) smokers17 (4)12 (3)\n\nPrimary outcome\nWe found no significant difference between the two groups in birth weight at delivery.']	glucose	CHEBI	[12051]	[12058]	BMJ_2012_Aug_30_345_e5605_T35
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_68	[11679]	[12262]	['Values are mean (SD) unless stated otherwiseBaseline characteristicIntervention group (n=383)Control group (n=398)Age (years)32.0 (4.2)32.0 (4.2)Gestational age at recruitment (weeks)13.0 (2.3)12.9 (2.2)Weight (kg)73.8 (14.8)73.4 (13.7)Height (cm)166.3 (6.4)168.9 (6.5)Body mass index (kg/m2)26.8 (5.1)26.8 (4.8)Mid upper arm circumference (cm)29.5 (3.6)29.5 (3.4)Fasting glucose (mmol/L)4.5 (0.36)4.5 (0.38)Previous birth weight (g)4253 (261)4242 (236)No (%) smokers17 (4)12 (3)\n\nPrimary outcome\nWe found no significant difference between the two groups in birth weight at delivery.']	birth	GO_BP	[12096]	[12101]	BMJ_2012_Aug_30_345_e5605_T152
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_68	[11679]	[12262]	['Values are mean (SD) unless stated otherwiseBaseline characteristicIntervention group (n=383)Control group (n=398)Age (years)32.0 (4.2)32.0 (4.2)Gestational age at recruitment (weeks)13.0 (2.3)12.9 (2.2)Weight (kg)73.8 (14.8)73.4 (13.7)Height (cm)166.3 (6.4)168.9 (6.5)Body mass index (kg/m2)26.8 (5.1)26.8 (4.8)Mid upper arm circumference (cm)29.5 (3.6)29.5 (3.4)Fasting glucose (mmol/L)4.5 (0.36)4.5 (0.38)Previous birth weight (g)4253 (261)4242 (236)No (%) smokers17 (4)12 (3)\n\nPrimary outcome\nWe found no significant difference between the two groups in birth weight at delivery.']	birth	GO_BP	[12237]	[12242]	BMJ_2012_Aug_30_345_e5605_T153
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_68	[11679]	[12262]	['Values are mean (SD) unless stated otherwiseBaseline characteristicIntervention group (n=383)Control group (n=398)Age (years)32.0 (4.2)32.0 (4.2)Gestational age at recruitment (weeks)13.0 (2.3)12.9 (2.2)Weight (kg)73.8 (14.8)73.4 (13.7)Height (cm)166.3 (6.4)168.9 (6.5)Body mass index (kg/m2)26.8 (5.1)26.8 (4.8)Mid upper arm circumference (cm)29.5 (3.6)29.5 (3.4)Fasting glucose (mmol/L)4.5 (0.36)4.5 (0.38)Previous birth weight (g)4253 (261)4242 (236)No (%) smokers17 (4)12 (3)\n\nPrimary outcome\nWe found no significant difference between the two groups in birth weight at delivery.']	delivery	GO_BP	[12253]	[12261]	BMJ_2012_Aug_30_345_e5605_T154
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_69	[12263]	[12475]	['Similarly, we found no difference in mean birthweight centile, birth weight adjusted for maternal body mass index, gestation at delivery, infant’s sex, or ponderal index at birth between the two groups (table 2).']	birth	GO_BP	[12326]	[12331]	BMJ_2012_Aug_30_345_e5605_T155
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_69	[12263]	[12475]	['Similarly, we found no difference in mean birthweight centile, birth weight adjusted for maternal body mass index, gestation at delivery, infant’s sex, or ponderal index at birth between the two groups (table 2).']	gestation	GO_BP	[12378]	[12387]	BMJ_2012_Aug_30_345_e5605_T156
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_69	[12263]	[12475]	['Similarly, we found no difference in mean birthweight centile, birth weight adjusted for maternal body mass index, gestation at delivery, infant’s sex, or ponderal index at birth between the two groups (table 2).']	delivery	GO_BP	[12391]	[12399]	BMJ_2012_Aug_30_345_e5605_T157
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_69	[12263]	[12475]	['Similarly, we found no difference in mean birthweight centile, birth weight adjusted for maternal body mass index, gestation at delivery, infant’s sex, or ponderal index at birth between the two groups (table 2).']	birth	GO_BP	[12436]	[12441]	BMJ_2012_Aug_30_345_e5605_T158
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_70	[12476]	[12608]	['Fetal macrosomia (birth weight >4000 g) recurred in 189 (51%) of the intervention group and 199 (51%) of the control group (P>0.05).']	birth	GO_BP	[12494]	[12499]	BMJ_2012_Aug_30_345_e5605_T159
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	birth	GO_BP	[12997]	[13002]	BMJ_2012_Aug_30_345_e5605_T160
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	birth	GO_BP	[13048]	[13053]	BMJ_2012_Aug_30_345_e5605_T161
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	birth	GO_BP	[13127]	[13132]	BMJ_2012_Aug_30_345_e5605_T162
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	pregnancy	GO_BP	[13292]	[13301]	BMJ_2012_Aug_30_345_e5605_T163
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	abdominal	UBERON	[13450]	[13459]	BMJ_2012_Aug_30_345_e5605_T264
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	abdominal wall	UBERON	[13557]	[13571]	BMJ_2012_Aug_30_345_e5605_T265
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	glucose	CHEBI	[13649]	[13656]	BMJ_2012_Aug_30_345_e5605_T36
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	198Glucose	CHEBI	[13722]	[13732]	BMJ_2012_Aug_30_345_e5605_T37
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	blood	UBERON	[13821]	[13826]	BMJ_2012_Aug_30_345_e5605_T266
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	glucose	CHEBI	[13827]	[13834]	BMJ_2012_Aug_30_345_e5605_T38
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	Birth	GO_BP	[14197]	[14202]	BMJ_2012_Aug_30_345_e5605_T164
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	pregnancy	GO_BP	[14220]	[14229]	BMJ_2012_Aug_30_345_e5605_T165
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	birth	GO_BP	[14236]	[14241]	BMJ_2012_Aug_30_345_e5605_T166
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_72	[12734]	[14268]	['Values are mean (SD) unless stated otherwiseOutcomeIntervention group (n=372)Control group (n=387)Mean difference (95% CI)P valueBirth weight (g)4034 (510)4006 (497)28.6 (−45.6 to 102.8)0.449Birthweight centile70.5 (25.6)72.8 (25.6)−1.6 (−5.39 to 2.2)0.409No (%) birth weight >4000 g189 (51)199 (51)—0.88Length at birth (cm)52.9 (2.7)52.6 (2.1)0.263 (−0.13 to 0.655)0.189Head circumference at birth (cm)35.8 (1.3)35.7 (1.5)−0.00225 (−0.231 to 0.227)0.985Ponderal index at birth2.76 (3.8)2.75 (0.33)0.011 (−0.36 to 0.39)0.95Birthweight difference* from first pregnancy (g)−214.2 (541)−250.8 (512)−36.6 (−120.15 to 46.95)0.507Estimated fetal weight at 34 weeks (g)2631 (326)2616 (368)14.74 (−40.89 to 70.38)0.603Fetal abdominal circumference at 34 weeks (mm)315.8 (16.7)315.6 (19.2)−0.201 (−3.067 to 2.665)0.89Fetal anterior abdominal wall width at 34 weeks (mm)5.0 (1.3)5.1 (1.2)−0.108 (−0.323 to 0.107)0.323Fasting glucose at 28 weeks (mmol/L)4.45 (0.4)4.51 (0.6)−0.058 (−0.146 to 0.03)0.198Glucose challenge test at 28 weeks (mmol/L)6.47 (1.4)6.67 (1.7)−0.205 (−0.44 to 0.031)0.088Cord blood glucose (mmol/L)4.17 (1.1)4.16 (1.2)0.014 (−0.19 to 0.217)0.896Weight gain at 24 weeks (kg)5.3 (2.7)5.5 (2.7)−0.244 (−0.786 to 0.299)0.378Weight gain at 28 weeks (kg)7.1 (2.8)7.7 (3.0)−0.593 (−1.072 to −0.114)0.015Weight gain at 34 weeks (kg)10.1 (3.7)10.9 (3.9)−0.83 (−1.48 to −0.182)0.012Weight gain at 40 weeks (kg)12.2 (4.4)13.7 (4.9)−1.346 (−2.451 to −0.241)0.017\n*Birth weight in second pregnancy minus birth weight in first pregnancy.']	pregnancy	GO_BP	[14258]	[14267]	BMJ_2012_Aug_30_345_e5605_T167
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_74	[14412]	[14551]	['Women who received dietary intervention had significantly less gestational weight gain than did those who received no dietary intervention.']	gestational	GO_BP	[14475]	[14486]	BMJ_2012_Aug_30_345_e5605_T168
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_75	[14552]	[14769]	['At 40 weeks’ gestation, the mean gestational weight gain in the intervention group was 12.2 kg compared with 13.7 kg in the control group (mean difference −1.3, 95% confidence interval −2.4 to −0.2; P=0.01) (table 2).']	gestation	GO_BP	[14565]	[14574]	BMJ_2012_Aug_30_345_e5605_T169
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_75	[14552]	[14769]	['At 40 weeks’ gestation, the mean gestational weight gain in the intervention group was 12.2 kg compared with 13.7 kg in the control group (mean difference −1.3, 95% confidence interval −2.4 to −0.2; P=0.01) (table 2).']	gestational	GO_BP	[14585]	[14596]	BMJ_2012_Aug_30_345_e5605_T170
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_77	[14929]	[15297]	['Women in the intervention arm of the study were significantly less likely to exceed gestational weight gain recommendations as outlined by the Institute of Medicine (139/368 (38%) v 182/380 (48%); P=0.01).27Among women with a normal body mass index (18.5-24.9), 40/155 (26%) controls exceeded the guidelines compared with 25/162 (15%) of the intervention arm (P=0.02).']	gestational	GO_BP	[15013]	[15024]	BMJ_2012_Aug_30_345_e5605_T171
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_79	[15462]	[15674]	['We found no significant difference between the two groups in the proportion of women with a body mass index of greater than 30.0 who exceeded gestational weight gain guidelines (43/75 (57%) v 40/67 (60%); P=0.8).']	gestational	GO_BP	[15604]	[15615]	BMJ_2012_Aug_30_345_e5605_T172
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_80	[15675]	[15834]	['Overall, a significantly higher proportion of women in the control group had a glucose challenge test result of greater than 7.8 mmol/L at 28 weeks’ gestation.']	glucose	CHEBI	[15754]	[15761]	BMJ_2012_Aug_30_345_e5605_T39
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_80	[15675]	[15834]	['Overall, a significantly higher proportion of women in the control group had a glucose challenge test result of greater than 7.8 mmol/L at 28 weeks’ gestation.']	gestation	GO_BP	[15824]	[15833]	BMJ_2012_Aug_30_345_e5605_T173
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_81	[15835]	[16040]	['Similarly, a higher proportion of women in the control arm than in the intervention had either a fasting glucose at 28 weeks of 5.1 mmol/L or greater or a glucose challenge test of greater than 7.8 mmol/L.']	glucose	CHEBI	[15940]	[15947]	BMJ_2012_Aug_30_345_e5605_T40
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_81	[15835]	[16040]	['Similarly, a higher proportion of women in the control arm than in the intervention had either a fasting glucose at 28 weeks of 5.1 mmol/L or greater or a glucose challenge test of greater than 7.8 mmol/L.']	glucose	CHEBI	[15990]	[15997]	BMJ_2012_Aug_30_345_e5605_T41
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_82	[16041]	[16378]	['An equal number of women in each arm had formal glucose tolerance testing, and no significant difference existed in the incidence of gestational diabetes according to either Carpenter and Coustan criteria (7 v 9) or the American Diabetes Association criteria (12 v 18).2328Cord blood glucose was similar between the two groups (table 3).']	glucose	CHEBI	[16089]	[16096]	BMJ_2012_Aug_30_345_e5605_T42
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_82	[16041]	[16378]	['An equal number of women in each arm had formal glucose tolerance testing, and no significant difference existed in the incidence of gestational diabetes according to either Carpenter and Coustan criteria (7 v 9) or the American Diabetes Association criteria (12 v 18).2328Cord blood glucose was similar between the two groups (table 3).']	gestational	GO_BP	[16174]	[16185]	BMJ_2012_Aug_30_345_e5605_T174
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_82	[16041]	[16378]	['An equal number of women in each arm had formal glucose tolerance testing, and no significant difference existed in the incidence of gestational diabetes according to either Carpenter and Coustan criteria (7 v 9) or the American Diabetes Association criteria (12 v 18).2328Cord blood glucose was similar between the two groups (table 3).']	blood	UBERON	[16319]	[16324]	BMJ_2012_Aug_30_345_e5605_T267
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_82	[16041]	[16378]	['An equal number of women in each arm had formal glucose tolerance testing, and no significant difference existed in the incidence of gestational diabetes according to either Carpenter and Coustan criteria (7 v 9) or the American Diabetes Association criteria (12 v 18).2328Cord blood glucose was similar between the two groups (table 3).']	glucose	CHEBI	[16325]	[16332]	BMJ_2012_Aug_30_345_e5605_T43
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_83	[16380]	[16516]	['Caption (TABLE-WRAP): TABLE 3\n\n\u2002Comparison of maternal glucose concentrations at 28 weeks’ gestation in intervention and control groups.']	glucose	CHEBI	[16435]	[16442]	BMJ_2012_Aug_30_345_e5605_T44
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_83	[16380]	[16516]	['Caption (TABLE-WRAP): TABLE 3\n\n\u2002Comparison of maternal glucose concentrations at 28 weeks’ gestation in intervention and control groups.']	gestation	GO_BP	[16471]	[16480]	BMJ_2012_Aug_30_345_e5605_T175
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_84	[16517]	[17040]	['Values are numbers (percentages)MeasurementIntervention groupControl group28 week fasting glucose ≥5.1 mmol/L24/321 (7)41/352 (12)GCT >7.8 mmol/L54/350 (15)79/371 (21)*28 week fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L67/320 (21)100/352 (28)*GCT >8.3 mmol/L42/350 (12)52/371 (14)Gestational diabetes (Carpenter and Coustan criteria)227/350 (2)9/371 (2)Gestational diabetes (American Diabetes Association criteria)2712/350 (3)18/371 (5)\nGCT=glucose challenge test (serum glucose measured 1 hour after 50 g glucose load).']	glucose	CHEBI	[16607]	[16614]	BMJ_2012_Aug_30_345_e5605_T45
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_84	[16517]	[17040]	['Values are numbers (percentages)MeasurementIntervention groupControl group28 week fasting glucose ≥5.1 mmol/L24/321 (7)41/352 (12)GCT >7.8 mmol/L54/350 (15)79/371 (21)*28 week fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L67/320 (21)100/352 (28)*GCT >8.3 mmol/L42/350 (12)52/371 (14)Gestational diabetes (Carpenter and Coustan criteria)227/350 (2)9/371 (2)Gestational diabetes (American Diabetes Association criteria)2712/350 (3)18/371 (5)\nGCT=glucose challenge test (serum glucose measured 1 hour after 50 g glucose load).']	glucose	CHEBI	[16701]	[16708]	BMJ_2012_Aug_30_345_e5605_T46
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_84	[16517]	[17040]	['Values are numbers (percentages)MeasurementIntervention groupControl group28 week fasting glucose ≥5.1 mmol/L24/321 (7)41/352 (12)GCT >7.8 mmol/L54/350 (15)79/371 (21)*28 week fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L67/320 (21)100/352 (28)*GCT >8.3 mmol/L42/350 (12)52/371 (14)Gestational diabetes (Carpenter and Coustan criteria)227/350 (2)9/371 (2)Gestational diabetes (American Diabetes Association criteria)2712/350 (3)18/371 (5)\nGCT=glucose challenge test (serum glucose measured 1 hour after 50 g glucose load).']	Gestational	GO_BP	[16800]	[16811]	BMJ_2012_Aug_30_345_e5605_T176
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_84	[16517]	[17040]	['Values are numbers (percentages)MeasurementIntervention groupControl group28 week fasting glucose ≥5.1 mmol/L24/321 (7)41/352 (12)GCT >7.8 mmol/L54/350 (15)79/371 (21)*28 week fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L67/320 (21)100/352 (28)*GCT >8.3 mmol/L42/350 (12)52/371 (14)Gestational diabetes (Carpenter and Coustan criteria)227/350 (2)9/371 (2)Gestational diabetes (American Diabetes Association criteria)2712/350 (3)18/371 (5)\nGCT=glucose challenge test (serum glucose measured 1 hour after 50 g glucose load).']	Gestational	GO_BP	[16873]	[16884]	BMJ_2012_Aug_30_345_e5605_T177
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_84	[16517]	[17040]	['Values are numbers (percentages)MeasurementIntervention groupControl group28 week fasting glucose ≥5.1 mmol/L24/321 (7)41/352 (12)GCT >7.8 mmol/L54/350 (15)79/371 (21)*28 week fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L67/320 (21)100/352 (28)*GCT >8.3 mmol/L42/350 (12)52/371 (14)Gestational diabetes (Carpenter and Coustan criteria)227/350 (2)9/371 (2)Gestational diabetes (American Diabetes Association criteria)2712/350 (3)18/371 (5)\nGCT=glucose challenge test (serum glucose measured 1 hour after 50 g glucose load).']	glucose	CHEBI	[16961]	[16968]	BMJ_2012_Aug_30_345_e5605_T47
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_84	[16517]	[17040]	['Values are numbers (percentages)MeasurementIntervention groupControl group28 week fasting glucose ≥5.1 mmol/L24/321 (7)41/352 (12)GCT >7.8 mmol/L54/350 (15)79/371 (21)*28 week fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L67/320 (21)100/352 (28)*GCT >8.3 mmol/L42/350 (12)52/371 (14)Gestational diabetes (Carpenter and Coustan criteria)227/350 (2)9/371 (2)Gestational diabetes (American Diabetes Association criteria)2712/350 (3)18/371 (5)\nGCT=glucose challenge test (serum glucose measured 1 hour after 50 g glucose load).']	serum	UBERON	[16985]	[16990]	BMJ_2012_Aug_30_345_e5605_T268
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_84	[16517]	[17040]	['Values are numbers (percentages)MeasurementIntervention groupControl group28 week fasting glucose ≥5.1 mmol/L24/321 (7)41/352 (12)GCT >7.8 mmol/L54/350 (15)79/371 (21)*28 week fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L67/320 (21)100/352 (28)*GCT >8.3 mmol/L42/350 (12)52/371 (14)Gestational diabetes (Carpenter and Coustan criteria)227/350 (2)9/371 (2)Gestational diabetes (American Diabetes Association criteria)2712/350 (3)18/371 (5)\nGCT=glucose challenge test (serum glucose measured 1 hour after 50 g glucose load).']	glucose	CHEBI	[16991]	[16998]	BMJ_2012_Aug_30_345_e5605_T48
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_84	[16517]	[17040]	['Values are numbers (percentages)MeasurementIntervention groupControl group28 week fasting glucose ≥5.1 mmol/L24/321 (7)41/352 (12)GCT >7.8 mmol/L54/350 (15)79/371 (21)*28 week fasting glucose ≥5.1 mmol/L or GCT >7.8 mmol/L67/320 (21)100/352 (28)*GCT >8.3 mmol/L42/350 (12)52/371 (14)Gestational diabetes (Carpenter and Coustan criteria)227/350 (2)9/371 (2)Gestational diabetes (American Diabetes Association criteria)2712/350 (3)18/371 (5)\nGCT=glucose challenge test (serum glucose measured 1 hour after 50 g glucose load).']	glucose	CHEBI	[17026]	[17033]	BMJ_2012_Aug_30_345_e5605_T49
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_86	[17062]	[17285]	['Dietary assessment\nWe found no difference in the dietary glycaemic index between women in the intervention group and controls before the intervention (57.3 (SD 4.2) v 57.7 (4.0); mean difference −0.4, −0.9 to 0.18; P=0.17).']	glycaemic	GO_BP	[17119]	[17128]	BMJ_2012_Aug_30_345_e5605_T178
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_87	[17286]	[17560]	['After introduction of the low glycaemic index diet, the intervention group had a lower glycaemic index in the second trimester (56.1 (4.0) v 57.8 (3.7); mean difference −1.7, −2.2 to −1.15; P<0.001) and third trimester (56.0 (3.8) v 57.7 (3.9); −1.7, −2.2 to −1.1; P<0.001).']	trimester	GO_BP	[17403]	[17412]	BMJ_2012_Aug_30_345_e5605_T179
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_89	[17744]	[18043]	['After introduction of the low glycaemic index diet, the intervention group had a significantly lower glycaemic load in the second trimester (124.1 (32.5) v 140.0 (36.3); mean difference −15.9, −20.8 to −10.9; P<0.001) and third trimester (127.1 (30.4) v 139.9 (37.5); −12.8, −17.6 to −7.9; P<0.001).']	trimester	GO_BP	[17874]	[17883]	BMJ_2012_Aug_30_345_e5605_T180
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_90	[18044]	[18118]	['No difference existed between the two groups in energy intake at baseline.']	intake	GO_BP	[18099]	[18105]	BMJ_2012_Aug_30_345_e5605_T181
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_91	[18119]	[18384]	['After randomisation, women in the intervention group had significantly lower energy intake in the second trimester (7.6 (1.9) v 8.1 (2.0) MJ; mean difference −0.5, −0.77 to −0.22; P<0.01) and third trimester (7.6 (1.9) v 8.1 (2.0) MJ; −0.5, −0.77 to −0.22; P<0.01).']	trimester	GO_BP	[18224]	[18233]	BMJ_2012_Aug_30_345_e5605_T182
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_94	[18626]	[18865]	['Maternal outcomes\nWe found no significant difference in the rate of caesarean delivery between the two groups, although women in the intervention arm of the study delivered at a later gestational age than did those in the intervention arm.']	delivery	GO_BP	[18704]	[18712]	BMJ_2012_Aug_30_345_e5605_T183
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_94	[18626]	[18865]	['Maternal outcomes\nWe found no significant difference in the rate of caesarean delivery between the two groups, although women in the intervention arm of the study delivered at a later gestational age than did those in the intervention arm.']	delivered	GO_BP	[18789]	[18798]	BMJ_2012_Aug_30_345_e5605_T184
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_94	[18626]	[18865]	['Maternal outcomes\nWe found no significant difference in the rate of caesarean delivery between the two groups, although women in the intervention arm of the study delivered at a later gestational age than did those in the intervention arm.']	gestational	GO_BP	[18810]	[18821]	BMJ_2012_Aug_30_345_e5605_T185
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_97	[19070]	[19206]	['Four women in the intervention arm had a primary postpartum haemorrhage of greater than 500 mL, compared with five in the control group.']	postpartum	GO_BP	[19119]	[19129]	BMJ_2012_Aug_30_345_e5605_T186
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_98	[19207]	[19365]	['We found no difference in the incidence of anal sphincter injury between the two groups—four occurred in the intervention group and five in the control group.']	anal sphincter	UBERON	[19250]	[19264]	BMJ_2012_Aug_30_345_e5605_T269
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_99	[19366]	[19537]	['In both groups, women delivered at an earlier gestational age compared with their first pregnancies (281.1 (10.1) v 286.9 (6.6) days; mean difference −5.8, −7.03 to −4.6).']	delivered	GO_BP	[19388]	[19397]	BMJ_2012_Aug_30_345_e5605_T187
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_99	[19366]	[19537]	['In both groups, women delivered at an earlier gestational age compared with their first pregnancies (281.1 (10.1) v 286.9 (6.6) days; mean difference −5.8, −7.03 to −4.6).']	gestational	GO_BP	[19412]	[19423]	BMJ_2012_Aug_30_345_e5605_T188
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_99	[19366]	[19537]	['In both groups, women delivered at an earlier gestational age compared with their first pregnancies (281.1 (10.1) v 286.9 (6.6) days; mean difference −5.8, −7.03 to −4.6).']	pregnancies	GO_BP	[19454]	[19465]	BMJ_2012_Aug_30_345_e5605_T189
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_100	[19539]	[19682]	['Fetal outcomes\nIn total, 11 preterm deliveries at less than 37 weeks occurred—three in the intervention arm and eight in the controls (P>0.05).']	Fetal	GO_BP	[19539]	[19544]	BMJ_2012_Aug_30_345_e5605_T190
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_100	[19539]	[19682]	['Fetal outcomes\nIn total, 11 preterm deliveries at less than 37 weeks occurred—three in the intervention arm and eight in the controls (P>0.05).']	preterm	GO_BP	[19567]	[19574]	BMJ_2012_Aug_30_345_e5605_T191
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_100	[19539]	[19682]	['Fetal outcomes\nIn total, 11 preterm deliveries at less than 37 weeks occurred—three in the intervention arm and eight in the controls (P>0.05).']	deliveries	GO_BP	[19575]	[19585]	BMJ_2012_Aug_30_345_e5605_T192
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_101	[19683]	[19836]	['Of these, just three were at less than 34 weeks’ gestation—one at 28 weeks in the intervention arm and two at 28 and 33 weeks’ gestation in the controls.']	gestation	GO_BP	[19732]	[19741]	BMJ_2012_Aug_30_345_e5605_T193
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_101	[19683]	[19836]	['Of these, just three were at less than 34 weeks’ gestation—one at 28 weeks in the intervention arm and two at 28 and 33 weeks’ gestation in the controls.']	gestation	GO_BP	[19810]	[19819]	BMJ_2012_Aug_30_345_e5605_T194
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_102	[19837]	[19950]	['Six cases of shoulder dystocia occurred in total—two in the intervention group and four in the controls (P>0.05).']	shoulder	UBERON	[19850]	[19858]	BMJ_2012_Aug_30_345_e5605_T270
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_103	[19952]	[20100]	['Discussion\nWe have found that a low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia.']	pregnancy	GO_BP	[20012]	[20021]	BMJ_2012_Aug_30_345_e5605_T195
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_103	[19952]	[20100]	['Discussion\nWe have found that a low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia.']	birth	GO_BP	[20048]	[20053]	BMJ_2012_Aug_30_345_e5605_T196
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_104	[20101]	[20216]	['It did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance.']	gestational	GO_BP	[20156]	[20167]	BMJ_2012_Aug_30_345_e5605_T197
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_104	[20101]	[20216]	['It did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance.']	glucose	CHEBI	[20196]	[20203]	BMJ_2012_Aug_30_345_e5605_T50
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_105	[20218]	[20598]	['Comparison with existing literature\nIn recent years, interest has been increasing in the role of the glycaemic index in pregnancy, and in particular its potential to modulate fetal growth.293031Until now, the small number of intervention trials that have examined the use of a low glycaemic index diet in pregnancy suggested that it might be useful in preventing fetal macrosomia.']	pregnancy	GO_BP	[20338]	[20347]	BMJ_2012_Aug_30_345_e5605_T198
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_105	[20218]	[20598]	['Comparison with existing literature\nIn recent years, interest has been increasing in the role of the glycaemic index in pregnancy, and in particular its potential to modulate fetal growth.293031Until now, the small number of intervention trials that have examined the use of a low glycaemic index diet in pregnancy suggested that it might be useful in preventing fetal macrosomia.']	modulate	GO_BP	[20384]	[20392]	BMJ_2012_Aug_30_345_e5605_T199
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_105	[20218]	[20598]	['Comparison with existing literature\nIn recent years, interest has been increasing in the role of the glycaemic index in pregnancy, and in particular its potential to modulate fetal growth.293031Until now, the small number of intervention trials that have examined the use of a low glycaemic index diet in pregnancy suggested that it might be useful in preventing fetal macrosomia.']	pregnancy	GO_BP	[20523]	[20532]	BMJ_2012_Aug_30_345_e5605_T200
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_106	[20599]	[21289]	['The earliest publication by Clapp et al in 1997 included just 12 women but found that those on a low glycaemic index diet during pregnancy not only had lower gestational weight gains but also gave birth to infants with lower birth weights than did those on a high glycaemic index diet.13Moses et al in 2006 reported a study of 70 women who were assigned to receive dietary counselling that encouraged low glycaemic index carbohydrate foods or high fibre, moderate to high glycaemic index foods.18They found a significantly higher prevalence of large for gestational age infants in those on the high glycaemic index diet of 33% compared with just 3% in those on the low glycaemic index diet.']	pregnancy	GO_BP	[20728]	[20737]	BMJ_2012_Aug_30_345_e5605_T201
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_106	[20599]	[21289]	['The earliest publication by Clapp et al in 1997 included just 12 women but found that those on a low glycaemic index diet during pregnancy not only had lower gestational weight gains but also gave birth to infants with lower birth weights than did those on a high glycaemic index diet.13Moses et al in 2006 reported a study of 70 women who were assigned to receive dietary counselling that encouraged low glycaemic index carbohydrate foods or high fibre, moderate to high glycaemic index foods.18They found a significantly higher prevalence of large for gestational age infants in those on the high glycaemic index diet of 33% compared with just 3% in those on the low glycaemic index diet.']	gestational	GO_BP	[20757]	[20768]	BMJ_2012_Aug_30_345_e5605_T202
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_106	[20599]	[21289]	['The earliest publication by Clapp et al in 1997 included just 12 women but found that those on a low glycaemic index diet during pregnancy not only had lower gestational weight gains but also gave birth to infants with lower birth weights than did those on a high glycaemic index diet.13Moses et al in 2006 reported a study of 70 women who were assigned to receive dietary counselling that encouraged low glycaemic index carbohydrate foods or high fibre, moderate to high glycaemic index foods.18They found a significantly higher prevalence of large for gestational age infants in those on the high glycaemic index diet of 33% compared with just 3% in those on the low glycaemic index diet.']	birth	GO_BP	[20796]	[20801]	BMJ_2012_Aug_30_345_e5605_T203
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_106	[20599]	[21289]	['The earliest publication by Clapp et al in 1997 included just 12 women but found that those on a low glycaemic index diet during pregnancy not only had lower gestational weight gains but also gave birth to infants with lower birth weights than did those on a high glycaemic index diet.13Moses et al in 2006 reported a study of 70 women who were assigned to receive dietary counselling that encouraged low glycaemic index carbohydrate foods or high fibre, moderate to high glycaemic index foods.18They found a significantly higher prevalence of large for gestational age infants in those on the high glycaemic index diet of 33% compared with just 3% in those on the low glycaemic index diet.']	birth	GO_BP	[20824]	[20829]	BMJ_2012_Aug_30_345_e5605_T204
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_106	[20599]	[21289]	['The earliest publication by Clapp et al in 1997 included just 12 women but found that those on a low glycaemic index diet during pregnancy not only had lower gestational weight gains but also gave birth to infants with lower birth weights than did those on a high glycaemic index diet.13Moses et al in 2006 reported a study of 70 women who were assigned to receive dietary counselling that encouraged low glycaemic index carbohydrate foods or high fibre, moderate to high glycaemic index foods.18They found a significantly higher prevalence of large for gestational age infants in those on the high glycaemic index diet of 33% compared with just 3% in those on the low glycaemic index diet.']	carbohydrate	CHEBI	[21020]	[21032]	BMJ_2012_Aug_30_345_e5605_T51
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_106	[20599]	[21289]	['The earliest publication by Clapp et al in 1997 included just 12 women but found that those on a low glycaemic index diet during pregnancy not only had lower gestational weight gains but also gave birth to infants with lower birth weights than did those on a high glycaemic index diet.13Moses et al in 2006 reported a study of 70 women who were assigned to receive dietary counselling that encouraged low glycaemic index carbohydrate foods or high fibre, moderate to high glycaemic index foods.18They found a significantly higher prevalence of large for gestational age infants in those on the high glycaemic index diet of 33% compared with just 3% in those on the low glycaemic index diet.']	foods	CHEBI	[21087]	[21092]	BMJ_2012_Aug_30_345_e5605_T52
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_106	[20599]	[21289]	['The earliest publication by Clapp et al in 1997 included just 12 women but found that those on a low glycaemic index diet during pregnancy not only had lower gestational weight gains but also gave birth to infants with lower birth weights than did those on a high glycaemic index diet.13Moses et al in 2006 reported a study of 70 women who were assigned to receive dietary counselling that encouraged low glycaemic index carbohydrate foods or high fibre, moderate to high glycaemic index foods.18They found a significantly higher prevalence of large for gestational age infants in those on the high glycaemic index diet of 33% compared with just 3% in those on the low glycaemic index diet.']	gestational	GO_BP	[21153]	[21164]	BMJ_2012_Aug_30_345_e5605_T205
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_107	[21290]	[21465]	['More recently, Rhodes et al reported the results of a pilot study comparing a low glycaemic load diet with a low fat diet in a group of 46 overweight and obese pregnant women.']	pregnant	GO_BP	[21450]	[21458]	BMJ_2012_Aug_30_345_e5605_T206
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_108	[21466]	[21561]	['They used a much more intensive regimen, including weekly reinforcement and home food delivery.']	food	CHEBI	[21547]	[21551]	BMJ_2012_Aug_30_345_e5605_T53
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_109	[21562]	[21974]	['Their results in this particular patient group are very interesting and reflect our experience of little or no effect on birth weight but an improvement in maternal outcomes.32\n\nStrengths, limitations, and clinical implications\nThe ROLO study is a sufficiently powered, randomised controlled study, and we found no significant difference in absolute birth weight, birthweight centile, or incidence of macrosomia.']	birth	GO_BP	[21683]	[21688]	BMJ_2012_Aug_30_345_e5605_T207
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_109	[21562]	[21974]	['Their results in this particular patient group are very interesting and reflect our experience of little or no effect on birth weight but an improvement in maternal outcomes.32\n\nStrengths, limitations, and clinical implications\nThe ROLO study is a sufficiently powered, randomised controlled study, and we found no significant difference in absolute birth weight, birthweight centile, or incidence of macrosomia.']	birth	GO_BP	[21912]	[21917]	BMJ_2012_Aug_30_345_e5605_T208
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_109	[21562]	[21974]	['Their results in this particular patient group are very interesting and reflect our experience of little or no effect on birth weight but an improvement in maternal outcomes.32\n\nStrengths, limitations, and clinical implications\nThe ROLO study is a sufficiently powered, randomised controlled study, and we found no significant difference in absolute birth weight, birthweight centile, or incidence of macrosomia.']	birthweight	GO_BP	[21926]	[21937]	BMJ_2012_Aug_30_345_e5605_T209
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_110	[21975]	[22101]	['We did find that a low glycaemic index diet in pregnancy significantly reduced gestational weight gain, our secondary outcome.']	pregnancy	GO_BP	[22022]	[22031]	BMJ_2012_Aug_30_345_e5605_T210
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_110	[21975]	[22101]	['We did find that a low glycaemic index diet in pregnancy significantly reduced gestational weight gain, our secondary outcome.']	gestational	GO_BP	[22054]	[22065]	BMJ_2012_Aug_30_345_e5605_T211
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_111	[22102]	[22229]	['By 40 weeks’ gestation, women in the diet arm had gained 1.5 kg less than had those women who received no dietary intervention.']	gestation	GO_BP	[22115]	[22124]	BMJ_2012_Aug_30_345_e5605_T212
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_112	[22230]	[22704]	['A significant proportion of women in each arm of the study exceeded gestational weight gain guidelines as outlined by the Institute of Medicine.27Overall, 48% of women in our control group exceeded these guidelines, which is comparable to the 47.5% recently reported in a large low risk cohort of almost 8000 women.33Women who received the low glycaemic index diet, however, were significantly less likely to exceed these gestational weight gain guidelines; just 38% did so.']	gestational	GO_BP	[22298]	[22309]	BMJ_2012_Aug_30_345_e5605_T213
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_112	[22230]	[22704]	['A significant proportion of women in each arm of the study exceeded gestational weight gain guidelines as outlined by the Institute of Medicine.27Overall, 48% of women in our control group exceeded these guidelines, which is comparable to the 47.5% recently reported in a large low risk cohort of almost 8000 women.33Women who received the low glycaemic index diet, however, were significantly less likely to exceed these gestational weight gain guidelines; just 38% did so.']	gestational	GO_BP	[22652]	[22663]	BMJ_2012_Aug_30_345_e5605_T214
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_113	[22705]	[23172]	['Maternal weight gain during pregnancy has been independently linked to adverse obstetric outcomes.1134Excessive gestational weight gain also has potential maternal implications, such as an increased operative delivery rate,2a higher likelihood of postpartum weight retention,34and a predisposition to later obesity.353637\nAdditionally, we found that a low glycaemic index diet in pregnancy reduced the incidence of maternal glucose intolerance at 28 weeks’ gestation.']	pregnancy	GO_BP	[22733]	[22742]	BMJ_2012_Aug_30_345_e5605_T215
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_113	[22705]	[23172]	['Maternal weight gain during pregnancy has been independently linked to adverse obstetric outcomes.1134Excessive gestational weight gain also has potential maternal implications, such as an increased operative delivery rate,2a higher likelihood of postpartum weight retention,34and a predisposition to later obesity.353637\nAdditionally, we found that a low glycaemic index diet in pregnancy reduced the incidence of maternal glucose intolerance at 28 weeks’ gestation.']	gestational	GO_BP	[22817]	[22828]	BMJ_2012_Aug_30_345_e5605_T216
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_113	[22705]	[23172]	['Maternal weight gain during pregnancy has been independently linked to adverse obstetric outcomes.1134Excessive gestational weight gain also has potential maternal implications, such as an increased operative delivery rate,2a higher likelihood of postpartum weight retention,34and a predisposition to later obesity.353637\nAdditionally, we found that a low glycaemic index diet in pregnancy reduced the incidence of maternal glucose intolerance at 28 weeks’ gestation.']	postpartum	GO_BP	[22952]	[22962]	BMJ_2012_Aug_30_345_e5605_T217
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_113	[22705]	[23172]	['Maternal weight gain during pregnancy has been independently linked to adverse obstetric outcomes.1134Excessive gestational weight gain also has potential maternal implications, such as an increased operative delivery rate,2a higher likelihood of postpartum weight retention,34and a predisposition to later obesity.353637\nAdditionally, we found that a low glycaemic index diet in pregnancy reduced the incidence of maternal glucose intolerance at 28 weeks’ gestation.']	pregnancy	GO_BP	[23085]	[23094]	BMJ_2012_Aug_30_345_e5605_T218
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_113	[22705]	[23172]	['Maternal weight gain during pregnancy has been independently linked to adverse obstetric outcomes.1134Excessive gestational weight gain also has potential maternal implications, such as an increased operative delivery rate,2a higher likelihood of postpartum weight retention,34and a predisposition to later obesity.353637\nAdditionally, we found that a low glycaemic index diet in pregnancy reduced the incidence of maternal glucose intolerance at 28 weeks’ gestation.']	glucose	CHEBI	[23129]	[23136]	BMJ_2012_Aug_30_345_e5605_T54
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_113	[22705]	[23172]	['Maternal weight gain during pregnancy has been independently linked to adverse obstetric outcomes.1134Excessive gestational weight gain also has potential maternal implications, such as an increased operative delivery rate,2a higher likelihood of postpartum weight retention,34and a predisposition to later obesity.353637\nAdditionally, we found that a low glycaemic index diet in pregnancy reduced the incidence of maternal glucose intolerance at 28 weeks’ gestation.']	gestation	GO_BP	[23162]	[23171]	BMJ_2012_Aug_30_345_e5605_T219
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_114	[23173]	[23377]	['A significantly higher proportion of women in the control arm had either a fasting glucose concentration of 5.1 mmol/L or greater or a glucose challenge test result of greater than 7.8 mmol/L at 28 weeks.']	glucose	CHEBI	[23256]	[23263]	BMJ_2012_Aug_30_345_e5605_T55
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_114	[23173]	[23377]	['A significantly higher proportion of women in the control arm had either a fasting glucose concentration of 5.1 mmol/L or greater or a glucose challenge test result of greater than 7.8 mmol/L at 28 weeks.']	glucose	CHEBI	[23308]	[23315]	BMJ_2012_Aug_30_345_e5605_T56
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_115	[23378]	[23487]	['Despite this reduction, we saw no difference between the two groups in the incidence of gestational diabetes.']	gestational	GO_BP	[23466]	[23477]	BMJ_2012_Aug_30_345_e5605_T220
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_116	[23488]	[23924]	['Since the publication of the HAPO study in 2008,15however, a clear association between glucose concentrations below those diagnostic of gestational diabetes and several adverse outcomes of pregnancy is widely accepted.3839In line with our institutional policy on screening for gestational diabetes, we did not do formal glucose tolerance testing on all women; this may have limited the number of cases of gestational diabetes diagnosed.']	glucose	CHEBI	[23575]	[23582]	BMJ_2012_Aug_30_345_e5605_T57
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_116	[23488]	[23924]	['Since the publication of the HAPO study in 2008,15however, a clear association between glucose concentrations below those diagnostic of gestational diabetes and several adverse outcomes of pregnancy is widely accepted.3839In line with our institutional policy on screening for gestational diabetes, we did not do formal glucose tolerance testing on all women; this may have limited the number of cases of gestational diabetes diagnosed.']	gestational	GO_BP	[23624]	[23635]	BMJ_2012_Aug_30_345_e5605_T221
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_116	[23488]	[23924]	['Since the publication of the HAPO study in 2008,15however, a clear association between glucose concentrations below those diagnostic of gestational diabetes and several adverse outcomes of pregnancy is widely accepted.3839In line with our institutional policy on screening for gestational diabetes, we did not do formal glucose tolerance testing on all women; this may have limited the number of cases of gestational diabetes diagnosed.']	pregnancy	GO_BP	[23677]	[23686]	BMJ_2012_Aug_30_345_e5605_T222
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_116	[23488]	[23924]	['Since the publication of the HAPO study in 2008,15however, a clear association between glucose concentrations below those diagnostic of gestational diabetes and several adverse outcomes of pregnancy is widely accepted.3839In line with our institutional policy on screening for gestational diabetes, we did not do formal glucose tolerance testing on all women; this may have limited the number of cases of gestational diabetes diagnosed.']	gestational	GO_BP	[23765]	[23776]	BMJ_2012_Aug_30_345_e5605_T223
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_116	[23488]	[23924]	['Since the publication of the HAPO study in 2008,15however, a clear association between glucose concentrations below those diagnostic of gestational diabetes and several adverse outcomes of pregnancy is widely accepted.3839In line with our institutional policy on screening for gestational diabetes, we did not do formal glucose tolerance testing on all women; this may have limited the number of cases of gestational diabetes diagnosed.']	glucose	CHEBI	[23808]	[23815]	BMJ_2012_Aug_30_345_e5605_T58
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_116	[23488]	[23924]	['Since the publication of the HAPO study in 2008,15however, a clear association between glucose concentrations below those diagnostic of gestational diabetes and several adverse outcomes of pregnancy is widely accepted.3839In line with our institutional policy on screening for gestational diabetes, we did not do formal glucose tolerance testing on all women; this may have limited the number of cases of gestational diabetes diagnosed.']	gestational	GO_BP	[23893]	[23904]	BMJ_2012_Aug_30_345_e5605_T224
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_119	[24044]	[24260]	['We specifically excluded those with a previous history of gestational diabetes, as at our institution this group are routinely started on a low glycaemic index diet in subsequent pregnancies from the first trimester.']	gestational	GO_BP	[24102]	[24113]	BMJ_2012_Aug_30_345_e5605_T225
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_119	[24044]	[24260]	['We specifically excluded those with a previous history of gestational diabetes, as at our institution this group are routinely started on a low glycaemic index diet in subsequent pregnancies from the first trimester.']	pregnancies	GO_BP	[24223]	[24234]	BMJ_2012_Aug_30_345_e5605_T226
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_121	[24400]	[24600]	['Our selection criteria may have introduced a degree of selection bias towards women who were giving birth to larger babies owing to genetic potential rather than to aberrations in maternal metabolism.']	giving	GO_BP	[24493]	[24499]	BMJ_2012_Aug_30_345_e5605_T227
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_121	[24400]	[24600]	['Our selection criteria may have introduced a degree of selection bias towards women who were giving birth to larger babies owing to genetic potential rather than to aberrations in maternal metabolism.']	birth	GO_BP	[24500]	[24505]	BMJ_2012_Aug_30_345_e5605_T228
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_121	[24400]	[24600]	['Our selection criteria may have introduced a degree of selection bias towards women who were giving birth to larger babies owing to genetic potential rather than to aberrations in maternal metabolism.']	genetic	SO	[24532]	[24539]	BMJ_2012_Aug_30_345_e5605_T250
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_121	[24400]	[24600]	['Our selection criteria may have introduced a degree of selection bias towards women who were giving birth to larger babies owing to genetic potential rather than to aberrations in maternal metabolism.']	metabolism	GO_BP	[24589]	[24599]	BMJ_2012_Aug_30_345_e5605_T229
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_122	[24601]	[24674]	['Birth weight is a complex interplay of genetic and environmental factors.']	Birth weight	GO_BP	[24601]	[24613]	BMJ_2012_Aug_30_345_e5605_T230
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_122	[24601]	[24674]	['Birth weight is a complex interplay of genetic and environmental factors.']	genetic	SO	[24640]	[24647]	BMJ_2012_Aug_30_345_e5605_T251
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_123	[24675]	[25038]	['The proportion of infants weighing greater than 4000 g who are larger than expected owing to excess glucose transfer across the placenta as detected by fetal cord hyperinsulinaemia may be as low as 15-20%.40Our strict inclusion criteria might explain why the differences we observed in maternal outcomes did not translate into a difference in infant birth weight.']	glucose	CHEBI	[24775]	[24782]	BMJ_2012_Aug_30_345_e5605_T59
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_123	[24675]	[25038]	['The proportion of infants weighing greater than 4000 g who are larger than expected owing to excess glucose transfer across the placenta as detected by fetal cord hyperinsulinaemia may be as low as 15-20%.40Our strict inclusion criteria might explain why the differences we observed in maternal outcomes did not translate into a difference in infant birth weight.']	placenta	UBERON	[24803]	[24811]	BMJ_2012_Aug_30_345_e5605_T271
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_123	[24675]	[25038]	['The proportion of infants weighing greater than 4000 g who are larger than expected owing to excess glucose transfer across the placenta as detected by fetal cord hyperinsulinaemia may be as low as 15-20%.40Our strict inclusion criteria might explain why the differences we observed in maternal outcomes did not translate into a difference in infant birth weight.']	fetal cord	UBERON	[24827]	[24837]	BMJ_2012_Aug_30_345_e5605_T272
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_125	[25204]	[25440]	['All women recruited to the study were aware that they were selected because of the birth weight of their first child, and they may have been motivated to reduce the risk of delivering an infant of similar size in their second pregnancy.']	birth	GO_BP	[25287]	[25292]	BMJ_2012_Aug_30_345_e5605_T231
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_125	[25204]	[25440]	['All women recruited to the study were aware that they were selected because of the birth weight of their first child, and they may have been motivated to reduce the risk of delivering an infant of similar size in their second pregnancy.']	delivering	GO_BP	[25377]	[25387]	BMJ_2012_Aug_30_345_e5605_T232
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_125	[25204]	[25440]	['All women recruited to the study were aware that they were selected because of the birth weight of their first child, and they may have been motivated to reduce the risk of delivering an infant of similar size in their second pregnancy.']	pregnancy	GO_BP	[25430]	[25439]	BMJ_2012_Aug_30_345_e5605_T233
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_127	[25593]	[25789]	['Nonetheless, the finding of a significant difference between the two groups in terms of gestational weight gain and glucose intolerance would suggest that any potential Hawthorne effect was small.']	gestational	GO_BP	[25681]	[25692]	BMJ_2012_Aug_30_345_e5605_T234
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_127	[25593]	[25789]	['Nonetheless, the finding of a significant difference between the two groups in terms of gestational weight gain and glucose intolerance would suggest that any potential Hawthorne effect was small.']	glucose	CHEBI	[25709]	[25716]	BMJ_2012_Aug_30_345_e5605_T60
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_128	[25790]	[25904]	['Importantly, we identified no adverse outcomes associated with the use of a low glycaemic index diet in pregnancy.']	pregnancy	GO_BP	[25894]	[25903]	BMJ_2012_Aug_30_345_e5605_T235
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_129	[25905]	[26097]	['Potential benefits were seen, particularly in terms of limiting maternal gestational weight gain to within Institute of Medicine guidelines and an improvement in maternal glucose homoeostasis.']	gestational	GO_BP	[25978]	[25989]	BMJ_2012_Aug_30_345_e5605_T236
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_129	[25905]	[26097]	['Potential benefits were seen, particularly in terms of limiting maternal gestational weight gain to within Institute of Medicine guidelines and an improvement in maternal glucose homoeostasis.']	glucose	CHEBI	[26076]	[26083]	BMJ_2012_Aug_30_345_e5605_T61
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_130	[26098]	[26199]	['These findings were identified after a single formal small group dietetic session in early pregnancy.']	pregnancy	GO_BP	[26189]	[26198]	BMJ_2012_Aug_30_345_e5605_T237
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_132	[26306]	[26549]	['Conclusions\nWith more than one billion adults in the world now overweight and more than 600 million clinically obese,42effective strategies to combat the incidence of fetal macrosomia as a significant precursor of childhood obesity are needed.']	adults	UBERON	[26345]	[26351]	BMJ_2012_Aug_30_345_e5605_T273
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_134	[26682]	[26853]	['The use of a low glycaemic index diet in pregnancy is a simple, safe, and effective measure to improve maternal glucose homoeostasis and to reduce gestational weight gain.']	pregnancy	GO_BP	[26723]	[26732]	BMJ_2012_Aug_30_345_e5605_T238
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_134	[26682]	[26853]	['The use of a low glycaemic index diet in pregnancy is a simple, safe, and effective measure to improve maternal glucose homoeostasis and to reduce gestational weight gain.']	glucose	CHEBI	[26794]	[26801]	BMJ_2012_Aug_30_345_e5605_T62
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_134	[26682]	[26853]	['The use of a low glycaemic index diet in pregnancy is a simple, safe, and effective measure to improve maternal glucose homoeostasis and to reduce gestational weight gain.']	glucose homoeostasis	GO_BP	[26794]	[26814]	BMJ_2012_Aug_30_345_e5605_T239
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_134	[26682]	[26853]	['The use of a low glycaemic index diet in pregnancy is a simple, safe, and effective measure to improve maternal glucose homoeostasis and to reduce gestational weight gain.']	gestational	GO_BP	[26829]	[26840]	BMJ_2012_Aug_30_345_e5605_T240
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	gestational	GO_BP	[27038]	[27049]	BMJ_2012_Aug_30_345_e5605_T241
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	glucose	CHEBI	[27076]	[27083]	BMJ_2012_Aug_30_345_e5605_T63
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	birth	GO_BP	[27134]	[27139]	BMJ_2012_Aug_30_345_e5605_T242
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	pregnancy	GO_BP	[27192]	[27201]	BMJ_2012_Aug_30_345_e5605_T243
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	insulin	PR	[27214]	[27221]	BMJ_2012_Aug_30_345_e5605_T249
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	birth	GO_BP	[27269]	[27274]	BMJ_2012_Aug_30_345_e5605_T244
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	pregnancy	GO_BP	[27366]	[27375]	BMJ_2012_Aug_30_345_e5605_T245
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	birth	GO_BP	[27402]	[27407]	BMJ_2012_Aug_30_345_e5605_T246
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	gestational	GO_BP	[27509]	[27520]	BMJ_2012_Aug_30_345_e5605_T247
BMJ_2012_Aug_30_345_e5605	BMJ_2012_Aug_30_345_e5605_135	[26855]	[27585]	['What is already known on this topic\nFetal macrosomia is associated with significant maternal and neonatal morbidity and confers an elevated risk of childhood obesity\nMaternal weight, gestational weight gain, and maternal glucose homoeostasis all exert a significant influence on birth weight\nA low glycaemic diet blunts the mid and late pregnancy increase in insulin resistance and may predispose to normal infant birth weight and normal maternal weight gain\n\nWhat this study adds\nA low glycaemic index diet in pregnancy had no effect on infants’ birth weight in a group at risk of fetal macrosomia\nIt did, however, have a significant positive effect on gestational weight gain and on maternal glucose intolerance\n\nPubMed Central:']	glucose	CHEBI	[27549]	[27556]	BMJ_2012_Aug_30_345_e5605_T64
